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Abstract
Background: The diagnosis of abdominal tuberculosis (TB) is difficult, especially so in health care
facilities in developing countries where laparoscopy and colonoscopy are rarely available. There is
little information on abdominal TB in HIV infection. We estimated the prevalence and clinical
features of abdominal (excluding genitourinary) TB in HIV infected adults attending the University
Teaching Hospital, Zambia.
Methods: We screened 5,609 medical inpatients, and those with fever, weight loss, and clinical
features suggestive of abdominal pathology were evaluated further. A clinical algorithm was used
to specify definitive investigations including laparoscopy or colonoscopy, with culture of biopsies
and other samples.
Results:  Of 140 HIV seropositive patients with these features, 31 patients underwent full
evaluation and 22 (71%) had definite or probable abdominal TB. The commonest presenting
abdominal features were ascites and persistent tenderness. The commonest ultrasound findings
were ascites, para-aortic lymphadenopathy (over 1 cm in size), and hepatomegaly. Abdominal TB
was associated with CD4 cell counts over a wide range though 76% had CD4 counts <100 cells/μL.
Conclusion: The clinical manifestations of abdominal TB in our HIV-infected patients resembled
the well-established pattern in HIV-uninfected adults. Patients with fever, weight loss, abdominal
tenderness, abdominal lymphadenopathy, ascites and/or hepatomegaly in Zambia have a high
probability of abdominal TB, irrespective of CD4 cell count.
Background
The HIV epidemic in sub-Saharan Africa has contributed
to an increased incidence of pulmonary tuberculosis (TB),
but there is little information on changes in the frequency
or clinical manifestations of abdominal TB. The annual
risk of developing active TB, when co-infected with HIV, is
20 to 30 times the risk in seronegative individual [1,2]. In
Africa, TB is the leading cause of mortality and morbidity
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in HIV infected patients, causing up to 41% of HIV-related
deaths in Zaire [3]. In Zambia, the number of newly diag-
nosed cases of TB increased from 8,246 (124/100,000) in
1985 to 38,863 (409/100,000) in 1996 and 52,000 (512/
100,000) in 2000 [2]. HIV infection is associated with a
rise in the proportion of extrapulmonary TB, including
pleural, pericardial, meningeal, lymphadenopathic, dis-
seminated, and bone and joint infections. The proportion
of extrapulmonary infection increases as the immunosup-
pression deepens [4,5]. In one estimate, the ratio of
extrapulmonary to pulmonary disease increased from
20:80 in early HIV infection to 50:50 in late HIV infection
[6]. As intra-abdominal tuberculosis is difficult to diag-
nose [7], the contribution of abdominal infection may be
higher than previous estimates suggest, but there have
been few papers which specifically address this important
question. Furthermore, the extent to which the manifesta-
tions of abdominal tuberculosis are altered by HIV infec-
tion is unknown; we are aware of only one paper which
addresses this [8].
The difficulty in diagnosing abdominal TB is due to the
lack of efficient and sensitive diagnostic tools as well as its
variable anatomical location. Symptoms of abdominal TB
are insidious and non-specific which can be mistaken for
the constitutional symptoms and signs of HIV disease. In
resource-limited settings, there are very few diagnostic
tools from which to choose. Microscopy is the most rapid
diagnostic tool, which in ideal settings can produce same
day results, but it is very insensitive, especially in severely
immunocompromised individuals [6]. Culture systems
are sensitive, but often take up to four weeks to obtain
conclusive results even with enhanced culture systems and
these approaches to enable more sensitive and rapid TB
diagnosis are not yet available in most developing country
settings [9]. Stool culture techniques are of limited value
due to the high rates of contamination from other micro-
organisms and to uncertainty about the significance of
isolation of faecal mycobacteria [10]. Most importantly,
diagnosis of abdominal TB is limited by the invasiveness
and expense of the procedures needed to obtain appropri-
ate samples for histology and/or culture. Laparoscopy or
laparotomy, colonoscopy and/or percutaneous biopsy of
liver or kidneys may all be required, and culture of ascitic
fluid, though more accessible, is insensitive (35% culture
positive in a series of patients with peritoneal TB) [7,11].
Ultrasound imaging gives very useful, though not defini-
tive, information [12] but it has not been systematically
evaluated in HIV infected patients in Africa. This is impor-
tant as HIV-related lymphadenopathy may alter the pre-
dictive value of established ultrasound findings.
In an autopsy study done in the Ivory Coast to study the
causes of wasting, 44% of wasted HIV positive patients
who died had TB [13], indicating that weight loss suggests
TB in HIV-infected Africans. The other common clinical
features of abdominal TB are: fever, abdominal pain, diar-
rhoea, ascites, hepatomegaly, and splenomegaly
[6,7,14,15]. Due to the indolent course of the disease
these symptoms often continue for a prolonged period of
time before a diagnosis is reached [7]. A heightened clini-
cal suspicion is important because only 15–20% of
abdominal TB patients have concomitant active pulmo-
nary tuberculosis [16].
The aims of our study were to obtain a preliminary esti-
mate of the prevalence of abdominal TB in symptomatic
HIV-infected patients in the principal in-patient facility in
Zambia, assess the level of immunodeficiency in those
with abdominal TB, and identify useful diagnostic tools
(particularly ultrasound) for a resource poor setting.
Based on previous studies of extrapulmonary TB, we
decided that HIV infected patients with fever (or night
sweats) and weight loss, together with symptoms or signs
indicating abdominal pathology, had a sufficiently high
clinical suspicion to warrant further evaluation. We used
laparoscopy and colonoscopy as gold standard diagnostic
techniques, coupled with mycobacterial culture on liquid
culture media for the diagnosis of abdominal TB, as these
permit definitive biopsy and visual accuracy can be up to
95% [17]. With these as reference standards, we set out to
evaluate diagnostic markers which might assist diagnosis
in other resource-poor hospitals.
Methods
Study population
The 1,200 bed University Teaching Hospital (UTH) in
Lusaka functions as the secondary and tertiary care hospi-
tal in the city as well as the major referral centre for all of
Zambia. Over a period of 27 weeks, from September 2005
until May 2006, all patients admitted to the medical
wards of UTH were reviewed by conducting twice weekly
ward rounds specifically for this purpose. The inclusion
criteria were fever and weight loss, with one or more of the
following: diarrhoea persisting for >1 month, ascites,
abdominal lymphadenopathy based on ultrasound,
mesenteric masses based on ultrasound, hepatomegaly or
splenomegaly, pancreatic enlargement based on ultra-
sound [18] or severe, unexplained focal or generalized
abdominal tenderness persisting for 7 days or more.
Assessment of weight loss was subjective only, based
upon the patient's recollection. A detailed clinical history,
physical examination, and laboratory investigations (see
below) were carried out, and an abdominal ultrasound
was conducted by the study team if not already done or to
confirm previous findings. The following were used as
exclusion criteria: HIV seronegative, solely pelvic or renal
abnormalities, anti-tuberculosis treatment for >1 week, orBMC Infectious Diseases 2009, 9:44 http://www.biomedcentral.com/1471-2334/9/44
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too sick to undergo laparoscopy or colonoscopy. The deci-
sion whether to perform laparoscopy or colonoscopy was
based on clinical and ultrasound findings (Figure 1).
HIV seropositive controls were recruited for the purpose
of evaluating the specificity of ultrasound findings (espe-
cially lymphadenopathy). These were recruited from the
HIV clinic at UTH, but they were excluded if they had any
of the inclusion criteria suggesting pathology mentioned
above within the previous month, any abdominal pathol-
ogy, or if they had ever had TB.
Ethical approval for the study was given by the University
of Zambia Research Ethics Committee and the University
of Alabama at Birmingham, Alabama. Informed consent
was obtained from all subjects. An information sheet was
given to each participant in both English and the predom-
inant local language, Nyanja. Participants were able to
withdraw from the study upon request at any time. All
patients with definite or probable abdominal TB were
treated with an eight month regimen consisting of
rifampicin, isoniazid, pyrazinamide and ethambutol as
per national guidelines. Anti-retroviral therapy was made
available to all participants in this study who required it.
Definitions
For our study, abdominal tuberculosis was defined as TB
affecting the peritoneum, abdominal lymph nodes,
omentum, liver, spleen, and/or gastrointestinal tract. A
definitive diagnosis of TB was made by demonstration of
Mycobacterium tuberculosis infection via positive bacterio-
logical culture and/or  granulomatous inflammation on
histopathological examination with positive Ziehl-
Neelsen (ZN) staining on microscopy. A presumptive
diagnosis of TB was made when granulomatous inflam-
mation was seen on microscopy, or when visual inspec-
tion on laparoscopy was consistent with TB and the
patient's clinical response to anti-tuberculous treatment
was good. Laparoscopic features felt to be consistent with
TB for the purpose of making a presumptive diagnosis
were the presence of tubercles, fibroadhesive peritonitis,
or caseating lymphadenopathy. Diarrhoea was defined as
the passage of loose or watery stools more than 3 times in
24 hours.
Collection of biopsies for culture
Laparoscopies were carried out under general anaesthesia.
Two or three 10 mm and 5 mm ports were used to insert
biopsy forceps through which biopsies were taken. One
Diagnostic algorithm for evaluation of patients fulfilling inclusion criteria Figure 1
Diagnostic algorithm for evaluation of patients fulfilling inclusion criteria.
Fever and Weight loss
Excluded Severe diarrhoea persistent for > 1month, 
ascites, abdominal lymphadenopathy, 
mesenteric masses, hepatomegaly, 
splenomegaly, pancreatic enlargement, severe, 
unexplained focal or generalized abdominal 
tenderness persisting over 7 days
NO YES
Excluded HIV Test
NO YES
Ultrasound Excluded
NEG POS
CD4 Count
Severe diarrhoea persistent for > 
1month or unexplained focal or 
generalized abdominal tenderness 
persisting over 7 days
Laparoscopy with biopsies 
and cultures
NORMAL
Excluded
ABNORMAL
Gastroscopy and colonoscopy
NO YES
Excluded
Only pelvic or renal 
abnormalities
YES NOBMC Infectious Diseases 2009, 9:44 http://www.biomedcentral.com/1471-2334/9/44
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part of each biopsy was fixed in 10% formalin, embedded
in paraffin wax, and subjected to histopathological exam-
ination, PAS, and ZN staining. The other part was placed
in saline and submitted for MGIT culture. Colonoscopy
was performed under sedation with an Olympus FG-10
colonoscope and biopsies were taken from any diseased
mucosa, or from normal mucosa at the ileo-cecal valve if
no abnormality was seen. Pathology seen at colonoscopy
was not used as a means of making a presumptive diagno-
sis; positive microscopy or culture was required before
starting presumptive treatment. As endoscopic biopsies
are smaller than laparoscopic biopsies, three whole biop-
sies were collected into formalin for histology and three
into sterile saline for culture.
Laboratory methods and measurements
Biopsies were teased with sterile surgical blades and
homogenized in a sterile homogenizer for 15 minutes.
The vial was centrifuged at 4,000 g. In view of the poten-
tial contamination of colonic biopsies, all sediments were
decontaminated by washing with NaOH to a final con-
centration of 2% for 15 minutes. After neutralization with
phosphate buffer (pH 6.8), 0.5 ml of the centrifuged sed-
iment was pipetted into a Bactec MGIT 960 system tube
containing Enrichment supplement (0.8 ml; MGIT system
oleic acid-albumin-dextrose-citric acid) and an antimicro-
bial supplement (MGIT system PANTA [polymyxin B,
nalidixic acid, trimethoprim, and azlocillin]) and incu-
bated as described in the manufacturer's manual. The
MGIT system was programmed for 7 weeks incubation at
37°C. Positive samples were removed from the machine
and subjected to ZN staining for confirmation of the pres-
ence of mycobacteria, but no attempt was made to con-
firm the species.
For microscopy quality control, a known ZN positive con-
trol slide was stained simultaneously with the test slide. A
similar process was performed for Periodic acid Schiff
(PAS) staining. Each batch of MGIT system tubes was con-
trolled for support of growth by using M. tuberculosis
ATCC 27294, M. kansasii ATCC 12478, and M. fortuitum
ATCC 6841.
Blood was submitted for an HIV test (if the status was not
already known), CD4 count (FACScount, Becton Dickin-
son), full blood count, and liver function tests. Ascitic
fluid was tapped from those with ultrasound proven
ascites and the specimen was centrifuged at 4,000 g. Sedi-
ments were washed and prepared as above.
Statistical analysis
Fisher's exact test or the Student's t-test were used to deter-
mine statistical significance of associations, as appropri-
ate. The various findings on ultrasound were compared to
the final biopsy result of tuberculosis and were classified
as true positives (Tp), true negatives (Tn), false positives
(Fp), and false negative (Fn). Positive predictive value
(PPV) was calculated as Tp/total number of positives and
negative predictive value (NPV) was calculated as Tn
obtained/total number of negatives.
Results
During the study period, 5609 patients were reviewed and
evaluated. Of these, 140 fitted the main inclusion criteria.
We excluded 109 according to the previously mentioned
criteria (35 had been on antituberculosis therapy for more
than a week, 30 were too sick, 25 were discharged, 8 died
without autopsy, 7 declined to participate, and 4 did not
return for surgery). The study population, therefore, con-
sisted of 31 patients (Table 1). The age range was 18–54
years (mean 33.1 years). All patients were black Zam-
bians.
Of the 31 fully evaluated patients, laparoscopy was per-
formed on 23, colonoscopy on 5, and a final diagnosis
was made at autopsy for 3 patients who died before lapar-
oscopy could be carried out. MGIT cultures were positive
in 14 (45%) of 31 patients after anywhere between 21 and
48 days of incubation, and in 2 further patients (6%),
microscopy was positive even though cultures failed to
grow mycobacteria. In 6 further patients (19%), typical
laparoscopic appearances for abdominal TB were seen
and the patient responded to anti-tuberculous chemo-
therapy. Thus, 22 (71%) patients had definite (n = 16) or
presumptive (n = 6) abdominal TB. For 14 (45%) of these
31 patients, their HIV infection had not previously been
recognized. Three (10%) of TB patients admitted recent
contact with another TB person. CD4 counts were lower
in patients with evidence of TB (see below) than in
patients with no evidence of TB, but other haematological
parameters did not differ (Table 1).
The 9 patients with no evidence of TB had the following
diagnoses: 2 had diarrhoea of unknown cause, 1 had T cell
Non-Hodgkins lymphoma, and 6 had no diagnosis that
we could pinpoint. The 2 patients who had diarrhoea pre-
sented with fever and weight loss, abdominal tenderness,
and loose stools everyday for > 4 weeks; they had 3 stool
samples each that showed no organisms. Neither patient
had any positive findings consistent with TB on ultra-
sound and normal colonoscopies. The patient with lym-
phoma presented with fever, weight loss, diarrhoea for 2
weeks, significant chylous ascites (3 L were drained at
laparoscopy), hepatomegaly, mesenteric masses, fibrous
stranding throughout the abdomen, and abdominal lym-
phadenopathy. The 6 patients with no diagnosis pre-
sented in a similar manner to the patients with evidence
of TB, but biopsies showed non-granulomatous inflam-
mation only and we were unable to confirm response to
anti-tuberculous chemotherapy because they were lost to
follow-up.BMC Infectious Diseases 2009, 9:44 http://www.biomedcentral.com/1471-2334/9/44
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Of the 16 TB patients (52%) who had ascites, 3 patients
(19%) had a positive MGIT culture for TB.
Ultrasound findings
The commonest ultrasonographic finding in the abdomi-
nal TB patients was ascites with or without fibrinous
stranding. Lymph nodes were also commonly identified:
they varied in size from 1.1 cm × 1.8 cm to 2 cm × 3 cm
and were found in the para-aortic or porta hepatic region.
Table 2 shows the ultrasound findings in the TB positive
patients and the PPV and NNV compared with biopsy
diagnosis. The ultrasound findings that were most predic-
tive were ascites with fibrinous stranding, hepatomegaly,
and mesenteric mass, though none of the findings had a
useful negative predictive value.
None of 28 HIV seropositive controls had ultrasono-
graphically detectable intra-abdominal lymphadenopa-
thy.
Laparoscopic Findings
The laparoscopic findings varied widely in the 23 patients
who underwent the procedure (Table 3). Of these
patients, 2 had to have a conversion to a mini-laparotomy
because of too many adhesions. The quantity of ascites
varied from 1.6 L to 5.0 L. Of the 17 patients with ascites,
88% had straw coloured ascites and 12% had yellowish-
green coloured ascites.
Colonoscopy Findings
Of our three patients that had colonoscopies and were
finally diagnosed with TB, one had a classical appearance
of TB with nodular ulceration around the ileo-caecal
valve. The second had non-specific inflammation in the
cecum. The third had normal mucosa throughout.
Discussion
The dual epidemic of HIV and tuberculosis is probably the
greatest clinical challenge facing health workers in sub-
Table 1: Baseline characteristics, CD4 counts and haematology with respect to final diagnosis
All patients
(n = 31)
Evidence of TB (n = 22) No evidence of TB (n = 9) P
Sex (M:F) 8:23 7:15 1:8 0.38
Age (mean, SD) 33.4 (8.3) 30.7 (6.9) 39.8 (8) 0.003
Achieved secondary education 11 of 28 known 8 of 20 known 3 of 8 known 0.91
Clinical features
Abdominal tenderness 28 (90%) 19(86%) 9 (100%) 0.53
Generalized lymphadenopathy 12 (39% 9 (41%) 3 (33%) 1.00
Diarrhoea 11 (35%) 8 (36%) 3 (33%) 1.00
Night sweats 11 (35%) 8 (36%) 3 (33%) 1.00
Pallor 10 (32%) 5 (23%) 5 (55%) 0.10
Jaundice 6 (19%) 3 (14%) 3 (33%) 0.32
Haematological and immunological features
CD4 count (mean, SD), cells/μl 125 (128) 92 (115) 194 (134) 0.04
CD4 count below 100 cells/μl 19 (61%) 19 (77%) 2 (22%) 0.02
Haemoglobin concentration (mean, SD) g/dl 9.0 (2.4) 9.8 (2.7) 8.5 (1.7) 0.19
Leucocytes (mean, SD) ×109/l 6.3 (5) 5.1 (2.2) 8.9 (8.1) 0.048
Lymphocytes (mean, SD) % 26.5 (22) 22.5 (16) 34.6 (31) 0.16
Neutrophils (mean, SD) % 66.3 (21) 72.0 (16) 52 (30) 0.02
Platelets (mean, SD) ×109/l 224 (123) 232 (129) 205 (112) 0.59
P value refers to the difference between TB positive and negative using Fisher's exact test for proportions or t test for continuous variables. 
Significant differences were found for age, CD4 count and neutrophil count.
Table 2: Ultrasound findings in relation to evidence of TB
Finding TB positive TB negative PPV NPV
n = 31 22 9
Ascites 16 6 73% 33%
Ascites with fibrinous stranding 12 2 86% 41%
Intra-abdominal lymphadenopathy 9 4 69% 27%
Hepatomegaly 8 2 80% 33%
Splenomegaly 1 1 - -
Mesenteric mass 6 1 86% 33%
Pancreatic mass 0 0 - -
Note that if some cases of TB were missed through false negative cultures, then PPV and NPV will be under-estimated. Predictive values were not 
calculated when numbers were very small.
PPV, positive predictive value. NPV, negative predictive value.BMC Infectious Diseases 2009, 9:44 http://www.biomedcentral.com/1471-2334/9/44
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Saharan Africa. Current HIV seroprevalence in Lusaka is
probably close to the 2002 estimate of 22% such that a
huge pool of at-risk persons is fuelling the epidemic of
dual infection [19]. It has been known for many years that
increasing immunodeficiency changes the clinical presen-
tation so that extrapulmonary TB comes to dominate the
clinical picture; abdominal TB is an important manifesta-
tion of extrapulmonary TB [20,21].
Defining the incidence or prevalence of abdominal TB is
fraught with difficulties, and among these is the pressure
to implement presumptive treatment to save lives. This
was a major limitation of our study as a large proportion
of patients fulfilling our inclusion criteria could not be
studied because presumptive treatment invalidates culture
as a diagnostic tool. We cannot therefore estimate the fre-
quency of abdominal TB with precision, but our data sug-
gest that a large and under-diagnosed problem exists
amongst HIV positive adults in Zambia. If the 31 patients
studied are representative of the 140 meeting our clinical
criteria, then 99 (22/31 of 140) would have had abdomi-
nal TB. A survey in UTH of HIV seroprevalence in 2006
suggested that 73% of 201 medical inpatients were HIV-
infected (Nzali Kancheya and Atia Jordan, unpublished
data), so abdominal TB may be a larger problem than rec-
ognised previously. Of the 22 patients whom we found to
have abdominal TB, this diagnosis was not being actively
pursued by the admitting physicians in the majority, but
as our study reached completion, the diagnosis of abdom-
inal TB came to be considered more often among admit-
ting physicians.
Those affected ranged in age from 18 to 46 years and there
was a predominance of women over men. Our study
shows that abdominal TB can affect single organs as well
as multiple organs and can manifest itself in various ways.
In contrast to a previous study [8], ascites was the most
common manifestation in these HIV positive patients.
Although it has been described [18], we did not find any
ultrasound evidence of pancreatic involvement, but we
did not measure serum amylase or lipase.
It appears that abdominal TB in Zambia occurs largely in
people with CD4 cell counts of ≤150 cells/μL [22]. In a
study from Brazil, the mean CD4 cell count of patients
with extrapulmonary TB was 184/μL [21], but in our series
the median was 49/μL. This could be a genuine biological
difference or could be attributable to our patients having
more advanced disease at presentation. This may reflect
the poor state of Zambian health services which are strug-
gling to cope with a massive burden of HIV-related
pathology. We could identify no clear correlation between
CD4 count and laparoscopic findings with our sample
size.
It is important in a setting such as ours, with limited
resources and high HIV and TB con-infection rates, for
physicians to have a high clinical suspicion of abdominal
TB. Due to the difficulties in differentiating its non-spe-
cific presenting features and difficulty of diagnosis, we
aimed to create and test a useful algorithm. We found that
67% of patients that fitted our algorithm had abdominal
TB, suggesting that fever and weight loss with accompany-
ing abdominal symptoms and/or signs is an effective clin-
ical tool to identify persons requiring an abdominal TB
work-up. However, we almost certainly missed patients
with abdominal TB without fever, which in a recent series
was not present in up to one third of patients [23]. The
Table 3: Laparoscopic findings in patients with definite or presumptive abdominal TB
Finding Number CD4 count(s)
Ascites, thick fibrous sheet covering lever, irregular peritoneum and tubercles covering bowel 1 7
Fibroadhesive peritonitis with tubercles covering bowel, omentum, and peritoneum 3 14,48
Ascites, fibroadhesive peritonitis, mesenteric lymph nodes, and tubercles covering small bowel and omentum 1 20
Fibroadhesive peritonitis with irregular peritoneum and matted bowel in ileo-cecal region 1 35
Ascites and white liver ulcerations 13 5
Fibrous stranding in the ileo-cecal region and granulation and ulceration covering spleen 1 41
Ascites, fibroadhesive peritonitis with a mass in ileo-cecal region and tubercles covering liver and peritoneum 1 47
Ascites, a retroperitoneal mass, and tubercles covering the bowel 2 49
Fibroadhesive peritonitis and mesenteric lymph nodes 1 49
Fibrous stranding around liver covered with a few tubercles 1 92
Ascites, fibroadhesive peritonitis and tubercles on bowel 1 103
Fibroadhesive peritonitis with ascites 11 2 8
Ascites with tubercles covering omentum and liver 1 139
Fibrous stranding around pale liver with small yellow ulcerations 1 214
Ascites, discoloured liver and caseating mesenteric lymph nodes 1 490
Ascites with tubercles covering the parietal peritoneum 1 -
Ascites, peritoneum covered with pus and caseating mesenteric lymph nodes 1 -
- indicates missing CD4 countBMC Infectious Diseases 2009, 9:44 http://www.biomedcentral.com/1471-2334/9/44
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majority of adults with HIV-related diarrhoea do not have
fever and would not have been recruited to our study. In
those that do have both of these features we believe it is
important to consider abdominal tuberculosis, especially
if blood cultures are negative.
In patients with fever and weight loss, the most predictive
diagnostic markers were ultrasound detection of ascites
(PPV of 73%), hepatomegaly (80%), and/or fibrous
stranding (86%). Although abdominal lymphadenopathy
had only moderate predictive value (69%), it is important
to note that no controls had lymphadenopathy, so this
finding should be reason for further investigation in HIV
positive patients. If, as we suspect, some of the 6 patients
with no confirmed diagnosis actually had abdominal TB,
the PPV would be under-estimated. This could have hap-
pened if inaccurate targeting of biopsies missed the best
tissue for biopsy, or if the mycobacteria had been killed by
patients having been on anti-tuberculous chemotherapy
for longer than they said.
Ascites culture was only positive in 25% of patients with
this clinical feature. Our result was lower than that found
in other studies [11], but it should be noted that previous
studies did not separate findings among HIV positive and
HIV negative patients.
Table 3 shows the diverse range of diagnostic appearances
with laparoscopy of abdominal TB, including TB solely
affecting the liver, spleen, peritoneum, or bowel, as well as
a combination of these organs. In other laparoscopic stud-
ies, abdominal TB is categorized in discrete presentations.
Bhargava et al. divided peritoneal TB into three types [17],
but our findings do not fit such a clean pattern. It is not
clear whether this is due to findings being subjective or
whether it is because all our patients were HIV positive.
For our patients that underwent colonoscopy, we noted
that it is possible for normal looking mucosa to be colo-
nized by M. tuberculosis. In the patient with positive visual
findings we noted that the appearance was similar to
other descriptions [24], including nodular ulceration in
the ileal-caecal region.
Conclusion
Our recommendations are that people with fever and
weight loss with the features we have described should
undergo ultrasound examination. The presence of ascites
(especially with fibrinous stranding), hepatomegaly, or
lymphadenopathy indicates that TB is likely and in set-
tings where laparoscopy and colonoscopy would be
impractical, as in much of Africa, early presumptive treat-
ment is warranted. Lapatoromy may be necessary for
those who do not respond to presumptive treatment.
Ultrasound can also virtually rule out alternative diag-
noses such as hepatic abscess, and abdominal lymphade-
nopathy is much more commonly due to abdominal TB
than lymphoma. The most important point we can make
is to keep a high index of suspicion for this difficult diag-
nosis as TB is treatable. If this simple message can be
brought to the attention of primary care services we might
be able to evaluate patients at an earlier stage of disease.
The fact that 11 patients died waiting for treatment under-
lines the imperative to commence treatment promptly
when clinical suspicion is high.
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